IPH — Innate Pharma SA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for Innate Pharma SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	120	101	92.5	80.8	34.3
Net Total Accounts Receivable
Net Total Receivables	13.5	31	46.5	1.64	7.61
Prepaid Expenses
Total Other Current Assets
Total Current Assets	138	140	148	85.7	46.7
Net Property, Plant And Equipment	10.2	8.54	6.32	5.13	4.36
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	267	208	184	111	62.7
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	79.9	41.3	39.6	33	36.6
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	160	154	132	102	84.4
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	107	54.2	51.9	8.83	-21.7
Total Liabilities & Shareholders' Equity	267	208	184	111	62.7
Total Common Shares Outstanding
Total Preferred Shares Outstanding